Reference
Casany-Fernandez R, et al. Letter to the Editor: Remission of Graves' Disease After Initiation of Ocrelizumab in Patients with Multiple Sclerosis. Thyroid 33 : 267-269, No. 2, Feb 2023. Available from: URL: http://doi.org/10.1089/thy.2022.0398
Rights and permissions
About this article
Cite this article
Alemtuzumab/interferon-β. Reactions Weekly 1966, 23 (2023). https://doi.org/10.1007/s40278-023-43476-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-43476-y